elevate research properties
Elevate Research Properties develops, manages, and operates premier life science real estate facilities across three New York City assets, serving biotechnology, pharmaceutical, and research tenants. It is a wholly-owned subsidiary of private equity firm Taconic Partners.
- Company typePrivate
- Founded-
- HeadquartersNew York, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What elevate research properties does
Elevate Research Properties is a New York-based life science real estate company that develops, manages, and operates premier laboratory and research facilities for life science tenants. The company is a wholly-owned subsidiary of Taconic Partners, a private equity firm, and is responsible for all activities across Taconic's life science real estate portfolio including acquisitions, debt and equity capital markets, design, development and construction, leasing, tenant community engagement, operations, and property management. Elevate's portfolio currently consists of three facilities: West End Labs at 125 West End Avenue, Hudson Research Center at 619 West 54th Street, and Iron Horse Labs.
The company serves life science organizations — including biotechnology, pharmaceutical, medical device, and related research entities — that require specialized laboratory infrastructure with specific HVAC, utility, and compliance capabilities that traditional commercial real estate typically does not provide. Its core offering is purpose-built or adapted wet-lab and research space delivered as a turnkey managed facility, enabling tenants to focus on scientific activity rather than real estate operations.
Elevate generates revenue through recurring commercial real estate leases, with pricing negotiated on a case-by-case basis and not publicly disclosed. Its go-to-market is enterprise field sales conducted through direct outreach by senior executives (Matthew Weir and Michael Adelstein, using tacon.com email domains) to prospective life science tenants. The corporate website is minimal and currently displays a 'Website Coming Soon' notice, with full portfolio detail pages listed as forthcoming — indicating the digital presence is still being built out.
elevate research properties firmographics
Firmographics- Name
- elevate research properties
- Legal name
- Elevate Research Properties
- Website
- https://elevateresearchproperties.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Elevate Research Properties develops, manages, and operates premier life science real estate facilities across three New York City assets, serving biotechnology, pharmaceutical, and research tenants. It is a wholly-owned subsidiary of private equity firm Taconic Partners.
- Ownership category
- akta.pro rank
elevate research properties industry classification
Industry- Product category
- Life Science Real Estate
- NAICS
- Real Estate Property Managers (53131)
- SIC
- Operators Of Nonresidential Buildings (6512), Real Estate Agents & Managers (For Others) (6531)
- akta.pro primary industry
- Life Sciences/Laboratory Property Management (BPAJAGAL)
- akta.pro secondary industry
- Life Sciences/Lab Tenant Representation (BPAJALAG)
Keywords
Where elevate research properties is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
elevate research properties business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Infrastructure, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Commercial Real Estate Leasing: Revenue generated through leasing laboratory and research space to life science companies. The company builds, manages, and operates premier life science real estate facilities, generating income through commercial lease arrangements with tenants in the life sciences sector.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
elevate research properties product offering
Product offeringCore offering
Elevate Research Properties develops and manages purpose-built life science real estate facilities, providing specialized laboratory and research spaces within New York City. The company leases and operates buildings engineered to meet the stringent infrastructure requirements of life science tenants, including biotech, pharmaceutical, and academic research organizations. Operating as a wholly-owned subsidiary of Taconic Partners, it holds and manages a portfolio of research properties across Manhattan.
Product overview
Elevate Research Properties is a life science real estate company that builds, manages, and operates premier life science real estate facilities in strategic core markets. The company operates as a wholly-owned subsidiary of Taconic Partners and is responsible for all activities in the life science portfolio including acquisitions, debt and equity capital markets, design, development and construction, leasing, tenant community engagement, operations, and property management. The portfolio consists of three distinct life science facilities: West End Labs (125 West End Avenue), Hudson Research Center (619 West 54th Street), and Iron Horse Labs.
Differentiator
Problem solved
Functional benefit
Products and services
- West End Labs
- Hudson Research Center
- Iron Horse Labs
Companies that use elevate research properties
Customer profileSegments1 record
Ideal customer profiles1 record
elevate research properties technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
elevate research properties partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
elevate research properties competitors and assessment
Company assessmentBroad incumbents
- Healthpeak Properties: Healthpeak Properties is a diversified REIT with a sizable life science segment alongside medical/outpatient office. While not purely life science, its lab/outpatient portfolio overlaps with Elevate's tenant base and asset category, providing a broad incumbent comparable.
- Trammell Crow Company (CBRE): Trammell Crow is a major commercial real estate developer (owned by CBRE) with an active life science development practice. It represents a large-scale incumbent competitor for lab development opportunities and institutional tenants relative to Elevate's focused NYC platform.
Direct peers
- King Street Properties: King Street Properties is a privately held developer and operator of life science real estate, with significant holdings in the Cambridge/Boston market. It is comparable to Elevate in operating model and tenant focus, though more concentrated in a different geographic cluster.
- Alexandria Real Estate Equities: Alexandria is the largest publicly traded REIT focused on life science real estate, operating mission-critical lab and office facilities for tenants including biotech, pharma, and government research organizations. It is the benchmark comp for any specialized life science operator including Elevate, with a far larger and more diversified cluster footprint.
- Breakthrough Properties: Breakthrough Properties is a privately held life science real estate developer backed by a major institutional investor, focused on developing and operating Class A lab facilities in top-tier clusters. It competes with Elevate for similar tenant relationships and development opportunities.
- BioMed Realty (Blackstone): BioMed Realty is a major life science real estate owner/operator now owned by Blackstone, with a portfolio concentrated in top-tier innovation clusters. It directly competes with Elevate for institutional life science tenants and acquisition opportunities, with a much larger capital base.
- Longfellow Real Estate Partners: Longfellow is a privately held real estate investment and development firm focused exclusively on life science facilities across major US innovation markets. It is a direct competitor to Elevate in serving biotech and pharma tenants with specialized lab space.
- IQHQ (Beacon Capital Partners): IQHQ is a specialized life science real estate developer/owner focused on premium lab and innovation campuses in core biotech clusters. It is a close comparable to Elevate in vertical integration, tenant focus, and premium asset positioning.
Regional players
- Deerfield Management: Deerfield is a healthcare investment firm with life science real estate and operating company holdings concentrated primarily in NYC's East Side (including the CureLife campus). It is a regional competitor for NYC life science tenants and real estate opportunities relative to Elevate.
Others
- New York City Economic Development Corporation (NYCEDC) - Life Science Initiatives: NYCEDC drives NYC life science cluster strategy and incentives through programs like LifeSci NYC, and influences demand, zoning, and capital flows into the NYC lab market that Elevate operates in. Not a competitor but a key ecosystem participant shaping Elevate's market.
Market position
Strengths1 record
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
elevate research properties social profiles
Digital presenceelevate research properties financial estimates
Financial estimateRevenue estimate
Valuation estimate
elevate research properties leadership team
Management profileNumber of profiles
Profiles2 records
elevate research properties funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
elevate research properties M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about elevate research properties
What does elevate research properties do?
Elevate Research Properties develops and manages purpose-built life science real estate facilities, providing specialized laboratory and research spaces within New York City. The company leases and operates buildings engineered to meet the stringent infrastructure requirements of life science tenants, including biotech, pharmaceutical, and academic research organizations. Operating as a wholly-owned subsidiary of Taconic Partners, it holds and manages a portfolio of research properties across Manhattan.
Is elevate research properties a public or private company?
elevate research properties is a private company. It is classified as corporate owned and is currently operating.
When was elevate research properties founded?
elevate research properties was founded in -1.
Where is elevate research properties based?
elevate research properties is headquartered in New York, United States, in the North America region.
How does elevate research properties make money?
One revenue line is on record: commercial Real Estate Leasing.
Who are elevate research properties's main competitors?
Broad incumbents on record are Healthpeak Properties and Trammell Crow Company (CBRE). Direct peers are King Street Properties, Alexandria Real Estate Equities, Breakthrough Properties, BioMed Realty (Blackstone), Longfellow Real Estate Partners and IQHQ (Beacon Capital Partners). Deerfield Management is listed as a regional player. New York City Economic Development Corporation (NYCEDC) - Life Science Initiatives is listed as an others.
Does elevate research properties have an API?
No public API is recorded for elevate research properties.
What industry is elevate research properties in?
elevate research properties's product category is Life Science Real Estate. Its primary akta.pro industry code is BPAJAGAL, Life Sciences/Laboratory Property Management, with a secondary code of BPAJALAG, Life Sciences/Lab Tenant Representation. Its NAICS code is 53131 and its SIC code is 6512.